National Vision Holdings, Inc.
EYENext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for EYE. That does not mean none is planned.
Get an email about EYE's next catalysts
Track National Vision Holdings (EYE) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
1 upcoming event in our data (earnings).See the timeline
1 upcoming, 0 past
EYE Earnings Report
EPS Est: $0.06 | FQ end Sep/2026 | Call: bmo
Market Overview
Stock performance and key metrics
Inactivated SARS-CoV-2 Vaccine (Vero cell)
COVID-19
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Whooping Cough
SARS-CoV-2 Vaccine (Vero Cell), Inactivated
COVID-19 Pneumonia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Inactivated SARS-CoV-2 Vaccine (Vero cell) | Phase 3 | COVID-19 | - | - |
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed | Phase 3 | Whooping Cough | - | - |
SARS-CoV-2 Vaccine (Vero Cell), Inactivated | Phase 3 | COVID-19 Pneumonia | - | - |
Frequently asked questions
What is in National Vision Holdings, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in National Vision Holdings, Inc.'s (EYE) pipeline across Phase 3. Its lead program is Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is National Vision Holdings, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for National Vision Holdings, Inc. (EYE) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track EYE biotech catalysts?→
Add EYE to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow National Vision Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.